David Brown, M.B.A.

Laboratory Manager
Institute for Therapeutic Innovation, University of Florida

Disclosure(s): Curza, Inc.: Grant/Research Support; Prokaryotics: Grant/Research Support; Spero Therapeutics: Grant/Research Support

Poster(s):

• 1695 - Combination Therapy for the Investigational Polymyxin SPR206 and Meropenem (MEM) Increases the Rapidity and Extent of Killing of Pseudomonas aeruginosa (PA) and Prevents the Bacterium from Emerging Resistant to Both Antibiotics
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET